Dysfunction of the ubiquitin-proteasome system in the cerebellum of aging Ts65Dn mice

Experimental Neurology

Volumn 232, Issue 2, 2011, Pages 114-118

  Necchi, Daniela ^a   Lomoio, Selene ^a   Scherini, Elda ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cerebellum; Down syndrome; Neurodegeneration; Ubiquitin proteasome system

Indexed keywords

CHYMOTRYPSIN; PROTEASOME; UBIQUITIN;

AGING; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CEREBELLUM; CEREBELLUM CORTEX; CEREBELLUM NUCLEUS; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PURKINJE CELL; UBIQUITINATION; WESTERN BLOTTING;

AGING; ANIMALS; CELL NUCLEUS; CEREBELLUM; DISEASE MODELS, ANIMAL; DOWN SYNDROME; MICE; MICE, NEUROLOGIC MUTANTS; NERVE DEGENERATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PURKINJE CELLS; UBIQUITIN; UBIQUITINATION;

EID: 80055006402     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.08.009     Document Type: Article

References (26)

1. Almeida C.G., Takahashi R.H., Gouras G.K. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci. 2006, 26:4277-4288.
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
3. Choi J.H.K., Berger J.D., Mazzella M.J., Morales-Corraliza J., Cataldo A.M., Nixon R.A., Ginsberg S.D., Levy E., Mathews P.M. Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model. J. Neurochem. 2009, 110:1818-1827.
4. Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ. 2005, 12:1178-1190.
5. Ding Q., Cecarini V., Keller J.N. Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications. Trends Neurosci. 2006, 30:31-36.
6. Goldberg A.L., Akopian T.N., Kisselev A.F., Lee D.H., Rohrwild M. New insight into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol. Chem. 1997, 378:131-140.
7. Gregori L., Fuchs C., Figueiredo-Pereira M.E., Van Nostrand W.E., Goldgaber D. Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 1995, 270:19702-19708.
8. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., Johnson R.M., Chen K., Sun Y., Carlson E., Alleva E., Epstein C.J., Mobley W.C. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13333-13338.
9. Huang Q., Figueiredo-Pereira M.E. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 2010, 15:1292-1311.
10. Hunter C.L., Bimonte-Nelson H.A., Nelson M., Eckman C.B., Granholm A.C. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol. Aging 2004, 25:873-884.
11. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 2000, 75:436-439.
12. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:46-64.
13. Lehman N.L. The ubiquitin proteasome system in neuropathology. Acta Neuropathol. 2009, 118:329-347.
14. Lomoio S., Scherini E., Necchi D. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice. Brain Res. 2009, 1297:198-206.
15. Mackenzie I.R.A., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010, 9:995-1007.
16. Malanga M., Romano M., Ferone A., Petrella A., Monti G., Jones R., Limatola E., Farina B. Misregulation of poly(ADP-ribose) polymerase-1 activity and cell type-specific loss of poly(ADP-ribose) synthesis in the cerebellum of aged rats. J. Neurochem. 2005, 93:1000-1009.
17. Muratani M., Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 2003, 4:192-201.
18. Necchi D., Lomoio S., Scherini E. Axonal abnormalities in cerebellar Purkinje cells of the Ts65Dn mouse. Brain Res. 2008, 1238:181-188.
19. Neumann M., Rademakers R., Roeber S., Baker M., Kreutzschmar H.A., Mackenzie R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009, 132:2922-2931.
20. Rogers N., Paine S., Bedford L., Layfield R. Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration. Neuropathol. Appl. Neurobiol. 2010, 36:113-124.
21. Stavreva D.A., Kawasaki M., Dundr M., Koberna K., Müller W.G., Tsujimura-Takahashi T., Komatsu W., Hayano T., Isobe T., Raska I., Misteli T., Takahashi N., McNally J.G. Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol. Cell. Biol. 2006, 26:5131-5145.
22. Tseng B.P., Green K.N., Chan J.L., Blurton-Jones M., Laferla F.M. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 2007, 29:1607-1618.
23. van Tijn P., Hol E.M., van Leeuwen F., Fischer D.F. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype. Prog. Neurobiol. 2008, 85:176-193.
24. Woulfe J.M. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress. Neuropathol. Appl. Neurobiol. 2007, 33:2-42.
25. Woulfe J., Gray D.A., Mackenzie I.R.A. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol. 2010, 20:589-597.
26. Zhang L., Ebenezer P.J., Dasuri K., Bruce-Keller A.J., Liu Y., Keller J.N. Proteasome inhibition modulates kinase activation in neural cells: relevance to ubiquitination, ribosomes and survival. J. Neurosci. Res. 2009, 87:3231-3233.